Bone marrow mononuclear cell cytosolic and nuclear components (BMMNC fraction)

Bone marrow mononuclear cells (BMMNCs) are a heterogeneous population of cells including hematopoietic stem cells, progenitor cells, lymphocytes, and monocytes (Source: PMC3659872). The cytosolic and nuclear components of these cells represent a complex mixture of proteins, nucleic acids, and organelles used primarily in biochemical assays to study intracellular signaling, transcription factor activity, or drug metabolism within the hematopoietic environment (Source: ChEMBL). Because this target encompasses the entire internal machinery of multiple cell types, it does not constitute a single therapeutic target. Instead, it serves as a biological matrix for identifying specific molecular interactions or evaluating the effects of compounds on bone marrow-derived cells. In pharmacological databases, this term is typically used to categorize assays performed on primary cell extracts rather than to define a specific receptor or enzyme (Source: PubChem).

Other names

BMMNC lysateBone marrow mononuclear cell subcellular fractionBMMNC cytosolic and nuclear extract

Not applicable for a complex cellular fraction; drugs interacting with this fraction typically target specific proteins such as kinases, nuclear receptors, or DNA contained within the mixture.